Perampanel in Patients with a History of Psychiatric Illness: Post Hoc Analysis of Four Randomised Phase III Studies and their Open-Label Extensions

被引：0
|
作者：
Malhotra, Manoj [1 ]
Patten, Anna [2 ]
Kanner, Andres [3 ]
机构：
[1] Eisai Inc, Woodcliff Lake, NJ USA
[2] Eisai Europe Ltd, Hatfield, Herts, England
[3] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
来源：
EPILEPSIA | 2021年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
253
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [31] Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study
    Jean-Yves Blay
    Patrick Schöffski
    Sebastian Bauer
    Anders Krarup-Hansen
    Charlotte Benson
    David R. D’Adamo
    Yan Jia
    Robert G. Maki
    British Journal of Cancer, 2019, 120 : 1026 - 1032
  • [32] Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study
    Blay, Jean-Yves
    Schoffski, Patrick
    Bauer, Sebastian
    Krarup-Hansen, Anders
    Benson, Charlotte
    D'Adamo, David R.
    Jia, Yan
    Maki, Robert G.
    BRITISH JOURNAL OF CANCER, 2019, 120 (11) : 1026 - 1032
  • [33] DEPRESSIVE SYMPTOMS IMPROVE WITH 1-YEAR ESLICARBAZEPINE ACETATE TREATMENT: A POOLED ANALYSIS OF 3 OPEN-LABEL EXTENSIONS OF PHASE III STUDIES IN PATIENTS WITH PARTIAL-ONSET SEIZURES
    Cramer, J.
    Hodoba, D.
    Ben-Menachem, E.
    Elger, C.
    Gil-Nagel, A.
    Maia, J.
    Nunes, T.
    Soares-da-Silva, P.
    EPILEPSIA, 2010, 51 : 117 - 117
  • [34] Efficacy and safety of adjunctive perampanel 4 mg/d for the treatment of focal seizures: A pooled post hoc analysis of four randomized, double-blind, phase III studies
    Steinhoff, Bernhard J.
    Patten, Anna
    Williams, Betsy
    Malhotra, Manoj
    EPILEPSIA, 2020, 61 (02) : 278 - 286
  • [35] Predictors of Achievement of Response With Cenobamate: Post-hoc Subset Analysis From a Phase 3, Open-Label Safety Study
    Wechsler, Robert
    Vossler, David G.
    Kerr, Wesley T.
    Stern, Sean
    Wade, Clarence T.
    Rosenfeld, William E.
    NEUROLOGY, 2023, 100 (17)
  • [36] Eribulin versus Dacarbazine in Previously Treated Patients with Advanced Liposarcoma or Leiomyosarcoma: a Randomised, Open-Label, Multicentre, Phase III Trial
    Ajgal, Z.
    Boudou-Rouquette, P.
    ONCOLOGIE, 2016, 18 (9-10) : 562 - 564
  • [37] Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer
    Cortes, J.
    Perez-Garcia, J.
    Levy, C.
    Gomez Pardo, P.
    Bourgeois, H.
    Spazzapan, S.
    Martinez-Janez, N.
    Chao, T. -C.
    Espie, M.
    Nabholtz, J. M.
    Gonzalez Farre, X.
    Beliakouski, V.
    Roman Garcia, J.
    Holgado, E.
    Campone, M.
    ANNALS OF ONCOLOGY, 2018, 29 (04) : 881 - 887
  • [38] Efficacy of Cenobamate by Concomitant Antiseizure Medications in Patients With Uncontrolled Focal Seizures: Post-hoc Analysis of a Phase 3, Multicenter, Open-Label Study
    Klein, Pavel
    Vossler, David G.
    Krauss, Gregory L.
    Sperling, Michael R.
    Kamin, Marc
    Rosenfeld, William E.
    NEUROLOGY, 2021, 96 (15)
  • [39] An analysis of feasibility of robotic colectomy: post hoc analysis of a phase III randomised controlled trial
    Fleming, Christina A.
    Celarier, Soline
    Fernandez, Benjamin
    Cauvin, Thomas
    Celerier, Bertrand
    Denost, Quentin
    JOURNAL OF ROBOTIC SURGERY, 2023, 17 (03) : 1057 - 1063
  • [40] An analysis of feasibility of robotic colectomy: post hoc analysis of a phase III randomised controlled trial
    Christina A. Fleming
    Soline Celarier
    Benjamin Fernandez
    Thomas Cauvin
    Bertrand Célérier
    Quentin Denost
    Journal of Robotic Surgery, 2023, 17 : 1057 - 1063
12345